SAN DIEGO--(BUSINESS WIRE)--Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets, today announced that David A. Ramsay, Halozyme’s CFO, will present at the Cowen and Company 29th Annual Healthcare Conference on Wednesday, March 18, 2009 at 8:00 a.m. EDT (5:00 a.m. PDT) at the Marriott Copley Place in Boston.
